Qingyi Wei, PhD

Professor in Population Health Sciences
Professor in Medicine
Member of the Duke Cancer Institute
Campus mail 103858, GSRB1 Room 3015C, Durham, NC 27710
Phone (919) 660-0562
Email address qingyi.wei@duke.edu

Qingyi Wei, MD, PhD, Professor in the Department of Medicine, is Associate Director for Cancer Control and Population Sciences, Co-leader of CCPS and Co-leader of Epidemiology and Population Genomics (Focus Area 1). He is a professor of Medicine and an internationally recognized epidemiologist focused on the molecular and genetic epidemiology of head and neck cancers, lung cancer, and melanoma. His research focuses on biomarkers and genetic determinants for the DNA repair deficient phenotype and variations in cell death. He is Editor-in-Chief of the open access journal "Cancer Medicine" and Associate Editor-in-Chief of the International Journal of Molecular Epidemiology and Genetics.

Area of Expertise: Epidemiology

Education and Training

  • Ph.D., Johns Hopkins Bloomberg School of Public Health, 1993
  • B.M., Nanjing Medical University (China), 1983

Publications

Ge, Jie, Hongliang Liu, Danwen Qian, Xiaomeng Wang, Patricia G. Moorman, Sheng Luo, Shelley Hwang, and Qingyi Wei. “Genetic variants of genes in the NER pathway associated with risk of breast cancer: A large-scale analysis of 14 published GWAS datasets in the DRIVE study..” Int J Cancer 145, no. 5 (September 1, 2019): 1270–79. https://doi.org/10.1002/ijc.32371.

PMID
31026346
Full Text

Chen, Ka, Hongliang Liu, Zhensheng Liu, Sheng Luo, Edward F. Patz, Patricia G. Moorman, Li Su, Sipeng Shen, David C. Christiani, and Qingyi Wei. “Genetic variants in RUNX3, AMD1 and MSRA in the methionine metabolic pathway and survival in nonsmall cell lung cancer patients..” Int J Cancer 145, no. 3 (August 1, 2019): 621–31. https://doi.org/10.1002/ijc.32128.

PMID
30650190
Full Text

Xu, Xinyuan, Danwen Qian, Hongliang Liu, Diana Cruz, Sheng Luo, Kyle M. Walsh, James L. Abbruzzese, Xuefeng Zhang, and Qingyi Wei. “Genetic variants in the liver kinase B1-AMP-activated protein kinase pathway genes and pancreatic cancer risk..” Mol Carcinog 58, no. 8 (August 2019): 1338–48. https://doi.org/10.1002/mc.23018.

PMID
30997723
Full Text

Dai, Juncheng, Jun Lv, Meng Zhu, Yuzhuo Wang, Na Qin, Hongxia Ma, Yong-Qiao He, et al. “Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations..” Lancet Respir Med, July 17, 2019. https://doi.org/10.1016/S2213-2600(19)30144-4.

PMID
31326317
Full Text

Luo, Xiaoning, Erich M. Sturgis, Zheng Yang, Yan Sun, Peng Wei, Zhensheng Liu, Qingyi Wei, and Guojun Li. “Lymphocyte telomere length predicts clinical outcomes of HPV-positive oropharyngeal cancer patients after definitive radiotherapy..” Carcinogenesis 40, no. 6 (July 6, 2019): 735–41. https://doi.org/10.1093/carcin/bgz019.

PMID
30721961
Full Text

Guo, Yi, Yun Feng, Hongliang Liu, Sheng Luo, Jeffrey W. Clarke, Patricia G. Moorman, Li Su, Sipeng Shen, David C. Christiani, and Qingyi Wei. “Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial..” Mol Carcinog 58, no. 7 (July 2019): 1094–1104. https://doi.org/10.1002/mc.23017.

PMID
30989732
Full Text

Feng, Yun, Hongliang Liu, Bensong Duan, Zhensheng Liu, James Abbruzzese, Kyle M. Walsh, Xuefeng Zhang, and Qingyi Wei. “Potential functional variants in SMC2 and TP53 in the AURORA pathway genes and risk of pancreatic cancer..” Carcinogenesis 40, no. 4 (June 10, 2019): 521–28. https://doi.org/10.1093/carcin/bgz029.

PMID
30794721
Full Text

Fang, Shenying, Tao Xu, Momiao Xiong, Xinke Zhou, Yuling Wang, Lauren E. Haydu, Merrick I. Ross, et al. “Role of Immune Response, Inflammation, and Tumor Immune Response-Related Cytokines/Chemokines in Melanoma Progression..” J Invest Dermatol, June 7, 2019. https://doi.org/10.1016/j.jid.2019.03.1158.

PMID
31176707
Full Text

Yang, Wenjun, Hongliang Liu, Bensong Duan, Xinyuan Xu, Dennis Carmody, Sheng Luo, Kyle M. Walsh, et al. “Three novel genetic variants in NRF2 signaling pathway genes are associated with pancreatic cancer risk..” Cancer Sci 110, no. 6 (June 2019): 2022–32. https://doi.org/10.1111/cas.14017.

PMID
30972876
Full Text

Li, Haoran, Xiaoxia Tong, Yuan Xu, Mengyun Wang, Hongji Dai, Tingyan Shi, Menghong Sun, Kexin Chen, Xi Cheng, and Qingyi Wei. “Functional genetic variants of RUVBL1 predict overall survival of Chinese patients with epithelial ovarian cancer..” Carcinogenesis, May 13, 2019. https://doi.org/10.1093/carcin/bgz092.

PMID
31083717
Full Text

Pages